Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways
V Mondelli, C Anacker, AC Vernon, A Cattaneo, S Natesan, M Modo, P Dazzan, S Kapur, CM Pariante
Translational Psychiatry | NATURE PUBLISHING GROUP | Published : 2013
Awarded by MRC
Awarded by Academy of Medical Sciences (AMS)
Awarded by Medical Research Council
Awarded by National Institute for Health Research
This research has been supported by the NIHR Biomedical Research Center for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London, and from an ECNP Young Scientist Award, a grant from the University of London Central Research Fund, and a Starter Grant for Clinical Lecturers from the Academy of Medical Sciences, the Wellcome Trust, and the British Heart Foundation to V Mondelli. The data collection was partially supported by MRC Grant G1002198 to S Kapur. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.